1. Introduction
===============

Previous evidence indicated that inflammation was associated with cardiovascular diseases,^\[[@R1],[@R2]\]^ certain cancer,^\[[@R3]\]^ and played a central role in the pathogenesis of metabolic diseases, including obesity, metabolic syndrome, and type 2 diabetes.^\[[@R4]--[@R7]\]^ Possible mechanisms in this relation included facilitation of atherosclerosis,^\[[@R8]\]^ development of insulin resistance,^\[[@R9]\]^ endoplasmic reticular stress,^\[[@R10]\]^ and change in gut microbiota.^\[[@R11]\]^ Several dietary factors had been reported to have an effect on the inflammatory markers. For instance, it had been reported that intake of red meat elevated inflammation, while consumption of fish,^\[[@R12]\]^ dairy,^\[[@R13]\]^ as well as nutrients such as zinc,^\[[@R14]\]^ and iron had an inverse association with the inflammatory markers.^\[[@R15]\]^ Moreover, Mediterranean-style diet which rich in whole grains, fruits, vegetables, legumes, and olive oil had been confirmed effective in reducing inflammation and its associated cardiovascular risk.^\[[@R16]\]^

Whole-grain foods had been reported to have a positive impact on reduced risk of developing type 2 diabetes,^\[[@R17],[@R18]\]^ certain type of cancers,^\[[@R19]--[@R21]\]^ and cardiovascular diseases.^\[[@R22],[@R23]\]^ This evidence led to health claims for increased consumption of whole-grain products in the USA, and Europe.^\[[@R24],[@R25]\]^ However, the mechanisms by which whole grains exert their beneficial effects were not fully elucidated, a great deal of research had directly gone into the association between whole grain intake and inflammation. Among those exploration, observational studies had suggested a relation between whole grains and decreased concentrations of circulating inflammatory markers,^\[[@R26]--[@R28]\]^ possibly thanks to its bioactive compounds, such as vitamins B, E, zinc, fiber, and selenium.^\[[@R29]\]^ Nevertheless, various factors, including smoking status, alcohol use, physical activity, total calories, and other dietary compounds could confound these results, and it was difficult to adjust for them, thus intervention clinical trials which reduced confounding factors were warranted. But unfortunately, so far, the number of intervention studies was relatively small when compared to observations and showed inconsistent conclusion on this issue. A review published in 2013 had been concluded that available evidence could not indicate a clear relation between whole grains and inflammation by summarizing findings from earlier intervention studies.^\[[@R30]\]^ Another systematic review in the same year included 5 intervention on the topic up to 2010 and qualitatively described the association between whole grain and the concentration of inflammatory markers was not significant.^\[[@R31]\]^ While recently, Roager et al and Vanegas et al conducted a randomized cross-over trial and a randomized controlled study separately and drew into a consistent conclusion that whole grains did have an inverse association with a decreased concentration of inflammatory markers.^\[[@R32],[@R33]\]^

It had been confirmed that whole grain intake could reduce the concentration of inflammatory markers in observational studies, but limited intervention trials did not reach consensus. However, to the best of our knowledge, no meta-analysis of intervention studies had been conducted. This meta-analysis aims to investigate the role of whole grain intake and the inflammatory markers with high-quality randomized trials.

2. Methods
==========

This study has been registered in PROSPERO(ID: CRD42018096533). However, all analyses were based on previous published studies, thus no ethical approval and patient consent are required.

2.1. Search strategy and selection criteria
-------------------------------------------

We did a systematic literature search of the PubMed, Web of Science, Embase, Medline, and Cochrane Library in order to identify randomized trials which reported the association between whole grain consumption and the inflammatory markers published before January 1, 2018. The following medical subject heading terms and text words were used in combination: "whole grain" or "cereal" or "wheat" or "brown rice", "inflammat" or "C-reactive protein" or "CRP" or "interleukin-6" or "IL-6" or "tumor necrosis factor-α" or "TNF-α", and "randomized trials". No restrictions on language. We also carefully reviewed the reference lists of retrieved articles and published systematic reviews and meta-analyses to identify additional studies that could contribute to the general discussion on this topic.

To select eligible studies, several inclusion criteria according to the so-called PICOs checklists were used:

1.  Population: people without taking any medicine that can change body inflammatory markers;

2.  Intervention: diet that is rich in whole grain;

3.  Control: refined grain diet adjusted for total calories intake;

4.  Outcomes: the concentration of inflammatory markers;

5.  Study design: randomized controlled studies or randomized cross-over trials. Case report, editorial letters, science reviews, and expert opinions were excluded.

2.2. Data extraction and quality assessment
-------------------------------------------

Two researchers (Yujie Xu and Qianyi Wan) independently performed data extraction from the retrieved studies. A third researcher (Ka Li) resolved any discrepancies that still exist after discussion. For each study, the following data were extracted into data-collection form: the first author\'s name, publication year, characteristics of participants, trial design, country of study, whole grain diet duration and doses, washout period (only for randomized cross-over trials) and the results of inflammatory markers.

The quality of eligible studies was independently judged by 2 researchers through assessing the risk of bias according to Jadad Scores (7-points) special for randomized controlled trial. Four sources of bias were evaluated: randomization methods, concealment of allocation, double blinding methods, and withdrawals and dropouts.

2.3. Statistical analysis
-------------------------

We examined the relation between whole grain diet and inflammatory markers on the basis of the effect estimates and their 95% confidence intervals (CI) in each included report. The amount of whole grain diet and inflammatory marker, such as IL-6, CRP, TNF-α, were measured as Mean with Standard Deviation (SD) that could calculate a standardized mean difference (SMD) with 95% CI. Within each clinical trial, the analysis population was defined as all randomly assigned participants. For the pooled analysis, we used either fixed effect model when heterogeneity was low or random effect model which take heterogeneity within and between studies into account, to calculate the summary SMD. All *P* values were derived from 2-sided tests, and we considered a *P* value less than 0.05 to be statistically significant.

Statistical heterogeneity across studies was assessed by the Cochrane *Q* test and *I*^*2*^ statistics. An *I*^*2*^ value of greater than 50%, or a *P* value less than .05 for the *Q* statistic, was taken to indicate heterogeneity. Subgroup analyses were performed to evaluate the consistency of the whole grain effect within specific subgroups of participants according to their baseline characteristics.

The presence of publication bias was investigated by using the Begg and Egger tests, and results were considered to indicate potential bias at *P* \< .05. We also carried out a traditional sensitivity analysis by excluding a study at a time to explore whether the results were driven by a study with extreme result. All data analysis was conducted by STATA software (version 12.0; StataSE). All statistical tests were 2-sided.

3. Results
==========

3.1. Study selection and study characteristics
----------------------------------------------

The PRISMA flowchart was shown in Figure [1](#F1){ref-type="fig"}. Initial queries identified a total of 205 articles from all databases and search methods after exclusion of 25 duplicated studies. Screening titles and abstracts yielded 39 full-text reports remaining, among these, 14 review or case-report and 11 animal trials were ruled out, and another 5 studies were not included because they focused on whole-grain fractions, leading to a total of 9 randomized trials finally included in this review. A manual search of the reference lists within the retrieved articles did not yield any new eligible study.

![Flow chart of article selection.](medi-97-e12995-g001){#F1}

A summary of study characteristics of individual study was presented in Table [1](#T1){ref-type="table"}. The included studies enrolled 838 participants randomly assigned to receive either standard diet or whole grain diet, published from 2007 to 2017. Of the 9 studies, 5^\[[@R33]--[@R37]\]^ were randomized controlled trial, 4^\[[@R32],[@R38]--[@R40]\]^ were randomized crossover study. Among these, 2 studies were conducted in America, 2 in United Kingdom, and each 1 in Australia, Denmark, Iran, Italy, and Sweden, covering different populations and regions.

###### 

Characteristics of studies investigating associations between whole grain diet and inflammatory markers^∗^.
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3.2. Quality of the included studies
------------------------------------

All 9 studies included in the analysis showed a low risk of selection bias. Randomization and concealment of allocation were performed in 7 studies (77.8%), a double blinding protocol was shown in 6 studies (66.7%), and withdrawals and dropouts details were identified in all studies (100%).

3.3. Main analysis
------------------

For the analyses of the relation of whole grain diet with inflammatory markers: CRP, IL-6, TNF-α, Interleukin-1β (IL-1β), we included 9 randomized trials that enrolled 838 participants reporting data on the issue. In the pooled analysis of all studies, whole grain exposure was significantly associated with the decreased concentration of inflammatory markers (SMD 0.16, 95% CI, 0.02--0.30). Specific analyses for CRP, IL-6, TNF-α, and IL-1β were also conducted, and yielded different outcomes. Among the 4 randomized crossover trials and 3 randomized controlled studies reporting data on CRP, we found that participants with whole grain diet were related with a significant decrease in the concentration of CRP (SMD 0.29, 95% CI, 0.08--0.50) with a low substantial heterogeneity between studies (*I*^*2*^ = 48.1%, *P* for heterogeneity = .07). Meanwhile, there was a significant decrease in the concentration of IL-6 for whole grain intake (SMD 0.19, 95%, 0.03--0.36), on the basis of 4 randomized controlled trials and 2 randomized crossover studies, and no statistically significant heterogeneity was observed (*I*^*2*^ = 36.6%, *P* for heterogeneity = .16). However, there were no statistically significant relation between whole grain diet and the level of TNF-α (SMD −0.15, 95% CI, −0.37 to 0.07) or IL-1β (SMD −0.04, 95%CI, −1.22 to 1.14). The results of main analysis and specific analyses was reported in Table [2](#T2){ref-type="table"} and Figure [2](#F2){ref-type="fig"}.

###### 

Meta-analysis of whole grain diet and the level of inflammatory markers^∗^.
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![Forest plot (fixed effects model) of whole grain consumption and inflammatory markers, including C-reactive protein, Tumor necrosis factor-α, Interleukin-6 and Interleukin-1β.](medi-97-e12995-g004){#F2}

3.4. Subgroup analysis
----------------------

The summary SMD of CRP and IL-6 with whole grain diet in strata of selected variables were presented in Table [3](#T3){ref-type="table"}. As for CRP, subgroup analysis showed that subgroups of "Obese or overweight participants" (SMD 0.35, 95% CI, 0.05--0.66), "\>18 years old" (SMD 0.32, 95% CI,0.05--0.59) and "whole grain doses \>100 g/day" (SMD 0.51, 95% CI, 0.29--0.72) were associated with significant decrease of CRP, but no relation in the "whole grain diet duration ≥8 weeks", "whole grain diet duration \<8 weeks", "whole grain doses \<100 g/d" subgroups. While no subgroup showed significant result about the concentration of IL-6.

###### 

Associations between whole grain diet and inflammatory markers^∗^.
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3.5. Sensitivity analyses and publication bias
----------------------------------------------

We also performed sensitivity analyses by withdrawing a study with extreme data and obtained materially unchanged results as in main analysis. Begg and Egger test was conducted to test publication bias between the included studies and did not indicate significant publication bias for Begg test (*P* = .86, Fig. [3](#F3){ref-type="fig"}) and Egger test (*P* = .71, Fig. [4](#F4){ref-type="fig"}).

![Publication bias of all studies by Begg test.](medi-97-e12995-g006){#F3}

![Publication bias of all studies by Egger test.](medi-97-e12995-g007){#F4}

4. Discussion
=============

In this pooled analysis of 9 randomized clinical studies with 838 participants from the United states, Australia, Europe, and Asia, we found an overall inverse association between whole grain products intake and inflammatory markers, including CRP, IL-6, TNF-α and IL-1β, matched for overall energy contents and macronutrient compositions. Notably, the inverse association with the concentration of CRP was also found in overweight participants, participants who were more than 18 years old and intake of whole grain that was more than 100 g per day.

The inverse relation between whole grain intake and inflammation had been consistently reported in many observational studies,^\[[@R17],[@R41],[@R42]\]^ but its interpretation remained controversial. First of all, it was reported that gluten and wheat germ agglutinin (WGA) had strong effect in activating pro-inflammatory immune system by increasing intestinal permeability,^\[[@R43],[@R44]\]^ and inducing specific T-cell,^\[[@R45]\]^ but whole grain products contained phytochemicals, like polyphenols, that can exert anti-inflammatory effects by possibly offsetting the effect of gluten and WGA.^\[[@R46]\]^ Secondly, whole grain were known to a source of short-chain fatty acids (SCFA) metabolized by gut microbiota,^\[[@R46]\]^ which had linked to secretion of gut hormones,^\[[@R47]\]^ immune homeostasis,^\[[@R48]\]^ and eventually led to whole grain-duced improvements on low-grade systematic inflammation.^\[[@R49]\]^ Meanwhile, it was proved that SCFA could in particular tight the junction of epithelial cells and increase the transport of secretory IgA to colon, and ultimately preserve the colonic mucosal barrier.^\[[@R50]--[@R52]\]^ Finally, a few studies investigated the effect of whole grain on the gut microbiota composition and found a whole grain-induced increase in *Faecalibacterium prausnitzii*, *Prevotella copri*, and Clostridiales.^\[[@R53],[@R54]\]^ Meanwhile, *Erythromicrobium ramosum* was reported to have contributed to the observed reduction in IL-6.^\[[@R55]\]^

In our meta-analysis, the decrease of CRP was also observed in obese participants and adults, that was consistent with previous findings.^\[[@R42],[@R56]\]^ Obesity was associated with increased inflammation and oxidative stress,^\[[@R57]\]^ and whole grain products had been confirmed to have a strong tight with weight loss in adults,^\[[@R58]\]^ so it was possible that whole grain also led to decreased inflammation simultaneously, but this study could not conclude the inverse association in healthy adults owing to the limited trials. Meanwhile, among children and adolescent, consumption of whole grains had been linked to a lower BMI and obesity, but its effect in inflammation was not so clear because only 2 studies retrieved in the meta-analysis.^\[[@R35],[@R39]\]^ Above all, the type of certain whole grain products differed among all the randomized clinical trials, therefore, even though intake of whole grain products more than 100 g per day was observed significant association between decreased inflammation, the recommended concentration of whole grain consumption was needed to treat with caution.

To our knowledge, this was the first meta-analysis conducted to evaluate the association between whole grain products and the concentration of inflammatory markers in randomized clinical trials. For the analysis, we found an inverse relation between them, and the results adjusted for overall energy and other macronutrients. Second, another major strength of our study was the relative larger number of participants, allowing a much greater possibility of performing further subgroup analysis. Third, between-study heterogeneity was small and publication bias was not checked, indicating that our results are stable.

However, there also were some limitations in this meta-analysis. First, the diversity of whole grain as a group of raw materials as well as the food processes used made it difficult to estimate real intake of whole grain, so a biomarker to improve estimation of whole grain was needed for interventional studies with higher quality. Plasma alkylresorcinol had shown great promise as a biomarker due to its stable and absorbable.^\[[@R59]\]^ In addition, several studies had used plasma alkylresorcinol to check compliance, and showed a possible relation between good compliance and outcomes.^\[[@R60]--[@R62]\]^ But in this meta-analysis, only 2 studies checked the plasma alkylresorcinol which could exaggerate or diminish the inverse association between whole grain and inflammation.^\[[@R32],[@R33]\]^ Second, of these circulating proteins as markers of inflammation, CRP was most commonly measured, followed by IL-6, and CRP was an acute-phase protein secreted by the liver in response to IL-6.^\[[@R63]\]^ Actually, fibrinogen, IL-2, IL-10, and TNF-α receptor-1 and receptor-2 could also reflect the inflammation status. Yet the meta-analysis was restricted to only the 4 most common markers that may cause the incomplete effect of whole grain on inflammation. Third, heterogeneity was found across studies even it was small, this might have resulted from the differences in design and differences in participants' characteristics, and most importantly, discrepancy in definition of whole grain products and interventional diet products. Finally, although randomized clinical trials had the greatest ability to exclude confounding factors, the possibility that some other un-measured factors or interaction between nutrients might have been partly responsible for the observed association could not be ruled out.

Furthermore, our meta-analysis pointed out the orientation of prospective studies in this field:

1.  Focus on a kind of grain or certain whole grain products to reduce the deviation of different whole grain products;

2.  Investigate deeply into the mechanism of the association and the effect of whole grain on health;

3.  Enlarge the included participants, such as healthy adults, obese or normal weight children and adolescent;

4.  Increase the interventional time of duration, and conduct follow-up to measure the forward effect of whole grain;

5.  Add multiple doses of congener whole grain food in 1 intervention to evaluate the effective dosage, ultimately help establish recommended intake in nutrients claim.

In conclusion, higher whole grain intake significantly decreased the concentration of inflammatory markers. From a public health perspective, our findings may provide useful insight and strong evidence in establishing future cereal foods recommendations. However, further well-designed studies are still needed.
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